1 1346 127 HYPERTENSION ANALYSIS OF STRESS REDUCTION USING MINDFULNESS MEDITATION AND YOGA: RESULTS FROM THE HARMONY RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE HARMONY STUDY WAS A RANDOMIZED, CONTROLLED TRIAL EXAMINING THE EFFICACY OF AN 8-WEEK MINDFULNESS-BASED STRESS REDUCTION (MBSR) PROGRAM FOR BLOOD PRESSURE (BP) LOWERING AMONG UNMEDICATED STAGE 1 HYPERTENSIVE PARTICIPANTS. METHODS: PARTICIPANTS DIAGNOSED WITH STAGE 1 HYPERTENSION BASED ON AMBULATORY BP WERE RANDOMIZED TO EITHER IMMEDIATE TREATMENT OF MBSR FOR 8 WEEKS OR WAIT-LIST CONTROL. PRIMARY OUTCOME ANALYSIS EVALUATED WHETHER CHANGE IN AWAKE AND 24-HOUR AMBULATORY BP FROM BASELINE TO WEEK 12 WAS SIGNIFICANTLY DIFFERENT BETWEEN THE 2 GROUPS. A WITHIN-GROUP BEFORE AND AFTER MBSR ANALYSIS WAS ALSO PERFORMED. RESULTS: THE STUDY ENROLLED 101 ADULTS (38% MALE) WITH BASELINE AVERAGE 24-HOUR AMBULATORY BP OF 135+/-7.9/82+/-5.8MM HG AND DAYTIME AMBULATORY BP OF 140+/-7.7/87+/-6.3 MMHG. AT WEEK 12, THE CHANGE FROM BASELINE IN 24-HOUR AMBULATORY BP WAS 0.4+/-6.7/0.0+/-4.9MM HG FOR THE IMMEDIATE INTERVENTION AND 0.4+/-7.8/-0.4+/-4.6MM HG FOR THE WAIT-LIST CONTROL. THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN INTERVENTION AND WAIT-LIST CONTROL FOR ALL AMBULATORY BP PARAMETERS. THE SECONDARY WITHIN-GROUP ANALYSIS FOUND A SMALL REDUCTION IN BP AFTER MBSR COMPARED WITH BASELINE, A FINDING LIMITED TO FEMALE SUBJECTS IN A SEX ANALYSIS. CONCLUSIONS: MBSR DID NOT LOWER AMBULATORY BP BY A STATISTICALLY OR CLINICALLY SIGNIFICANT AMOUNT IN UNTREATED, STAGE 1 HYPERTENSIVE PATIENTS WHEN COMPARED WITH A WAIT-LIST CONTROL GROUP. IT LEAVES UNTESTED WHETHER MBSR MIGHT BE USEFUL FOR LOWERING BP BY IMPROVING ADHERENCE IN TREATED HYPERTENSIVE PARTICIPANTS. CLINICAL TRIALS REGISTRATION: NCT00825526. 2014 2 74 43 A GROUP-BASED YOGA THERAPY INTERVENTION FOR URINARY INCONTINENCE IN WOMEN: A PILOT RANDOMIZED TRIAL. OBJECTIVE: THE AIM OF THIS STUDY IS TO EXAMINE THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION FOR MIDDLE-AGED AND OLDER WOMEN WITH URINARY INCONTINENCE. METHODS: WE CONDUCTED A PILOT RANDOMIZED TRIAL OF AMBULATORY WOMEN AGED 40 YEARS AND OLDER WITH STRESS, URGENCY, OR MIXED-TYPE INCONTINENCE. WOMEN WERE RANDOMIZED TO A 6-WEEK YOGA THERAPY PROGRAM (N = 10) CONSISTING OF TWICE WEEKLY GROUP CLASSES AND ONCE WEEKLY HOME PRACTICE OR A WAIT-LIST CONTROL GROUP (N = 9). ALL PARTICIPANTS ALSO RECEIVED WRITTEN PAMPHLETS ABOUT STANDARD BEHAVIORAL SELF-MANAGEMENT STRATEGIES FOR INCONTINENCE. CHANGES IN INCONTINENCE WERE ASSESSED WITH 7-DAY VOIDING DIARIES. RESULTS: THE MEAN (SD) AGE WAS 61.4 (8.2) YEARS, AND THE MEAN BASELINE FREQUENCY OF INCONTINENCE WAS 2.5 (1.3) EPISODES/D. AFTER 6 WEEKS, THE TOTAL INCONTINENCE FREQUENCY DECREASED BY 70% (1.8 [0.9] FEWER EPISODES/D) IN THE YOGA THERAPY VERSUS 13% (0.3 [1.7] FEWER EPISODES/D) IN THE CONTROL GROUP (P = 0.049). PARTICIPANTS IN THE YOGA THERAPY GROUP ALSO REPORTED AN AVERAGE OF 71% DECREASE IN STRESS INCONTINENCE FREQUENCY (0.7 [0.8] FEWER EPISODES/D) COMPARED WITH A 25% INCREASE IN CONTROLS (0.2 [1.1] MORE EPISODES/D) (P = 0.039). NO SIGNIFICANT DIFFERENCES IN REDUCTION IN URGENCY INCONTINENCE WERE DETECTED BETWEEN THE YOGA THERAPY VERSUS CONTROL GROUPS (1.0 [1.0] VERSUS 0.5 [0.5] FEWER EPISODES/D; P = 0.20). ALL WOMEN STARTING THE YOGA THERAPY PROGRAM COMPLETED AT LEAST 90% OF THE GROUP CLASSES AND PRACTICE SESSIONS. TWO PARTICIPANTS IN EACH GROUP REPORTED ADVERSE EVENTS UNRELATED TO THE INTERVENTION. CONCLUSIONS: FINDINGS PROVIDE PRELIMINARY EVIDENCE TO SUPPORT THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION TO IMPROVE URINARY INCONTINENCE IN WOMEN. 2014 3 1345 59 HYPERTENSION ANALYSIS OF STRESS REDUCTION USING MINDFULNESS MEDITATION AND YOGA (THE HARMONY STUDY): STUDY PROTOCOL OF A RANDOMISED CONTROL TRIAL. INTRODUCTION: HYPERTENSION (HTN) IS A LEADING RISK FACTOR FOR PREVENTABLE CARDIOVASCULAR DISEASE, WITH OVER ONE IN FIVE ADULTS AFFECTED WORLDWIDE. LIFESTYLE MODIFICATION IS A KEY STRATEGY FOR THE PREVENTION AND TREATMENT OF HTN. STRESS HAS BEEN ASSOCIATED WITH GREATER CARDIOVASCULAR RISK, AND STRESS MANAGEMENT IS A RECOMMENDED INTERVENTION FOR HYPERTENSIVES. STRESS REDUCTION THROUGH RELAXATION THERAPIES HAS BEEN SHOWN TO HAVE AN EFFECT ON HUMAN PHYSIOLOGY, INCLUDING LOWERING BLOOD PRESSURE (BP). HOWEVER, INDIVIDUALISED BEHAVIOURAL INTERVENTIONS ARE RESOURCE INTENSIVE, AND GROUP STRESS MANAGEMENT APPROACHES HAVE NOT BEEN VALIDATED FOR REDUCING HTN. THE HARMONY STUDY IS A PILOT RANDOMISED CONTROLLED TRIAL DESIGNED TO DETERMINE IF MINDFULNESS-BASED STRESS REDUCTION (MBSR), A STANDARDISED GROUP THERAPY, IS AN EFFECTIVE INTERVENTION FOR LOWERING BP IN STAGE 1 UNMEDICATED HYPERTENSIVES. METHODS AND ANALYSIS: MEN AND WOMEN UNMEDICATED FOR HTN WITH MEAN DAYTIME AMBULATORY BLOOD PRESSURE (ABP) >/=135/85 MM HG OR 24 H ABP >/=130/80 MM HG ARE INCLUDED IN THE STUDY. SUBJECTS ARE RANDOMISED TO RECEIVE MBSR IMMEDIATELY OR AFTER A WAIT-LIST CONTROL PERIOD. THE PRIMARY OUTCOME MEASURE IS MEAN AWAKE AND 24 H ABP. THE PRIMARY OBJECTIVE OF THE HARMONY STUDY IS TO COMPARE ABP BETWEEN THE TREATMENT AND WAIT-LIST CONTROL ARM AT THE 12-WEEK PRIMARY ASSESSMENT PERIOD. RESULTS FROM THIS STUDY WILL DETERMINE IF MBSR IS AN EFFECTIVE INTERVENTION FOR LOWERING BP IN EARLY UNMEDICATED HYPERTENSIVES. ETHICS AND DISSEMINATION: THIS RESEARCH PROJECT WAS APPROVED BY THE SUNNYBROOK RESEARCH ETHICS BOARD AND THE UNIVERSITY HEALTH NETWORK RESEARCH ETHICS BOARD (TORONTO, CANADA). PLANNED ANALYSES ARE IN FULL COMPLIANCE WITH THE PRINCIPLES OF THE DECLARATION OF HELSINKI. DATA COLLECTION WILL BE COMPLETED BY EARLY SPRING 2012. PRIMARY AND SECONDARY ANALYSIS WILL COMMENCE IMMEDIATELY AFTER DATA MONITORING IS COMPLETED; DISSEMINATION PLANS INCLUDE PREPARING PUBLICATIONS FOR SUBMISSION DURING THE SUMMER OF 2012. TRIAL REGISTRATION NUMBER: THIS STUDY IS REGISTERED WITH HTTP://CLINICALTRIALS.GOV (NCT00825526). 2012 4 1533 49 IYENGAR YOGA VERSUS ENHANCED USUAL CARE ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION TO STAGE I HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL. THE PREVALENCE OF PREHYPERTENSION AND STAGE 1 HYPERTENSION CONTINUES TO INCREASE DESPITE BEING AMENABLE TO NON-PHARMACOLOGIC INTERVENTIONS. IYENGAR YOGA (IY) HAS BEEN PURPORTED TO REDUCE BLOOD PRESSURE (BP) THOUGH EVIDENCE FROM RANDOMIZED TRIALS IS LACKING. WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF 12 WEEKS OF IY VERSUS ENHANCED USUAL CARE (EUC) (BASED ON INDIVIDUAL DIETARY ADJUSTMENT) ON 24-H AMBULATORY BP IN YOGA-NAIVE ADULTS WITH UNTREATED PREHYPERTENSION OR STAGE 1 HYPERTENSION. IN TOTAL, 26 AND 31 SUBJECTS IN THE IY AND EUC ARMS, RESPECTIVELY, COMPLETED THE STUDY. THERE WERE NO DIFFERENCES IN BP BETWEEN THE GROUPS AT 6 AND 12 WEEKS. IN THE EUC GROUP, 24-H SYSTOLIC BP (SBP), DIASTOLIC BP (DBP) AND MEAN ARTERIAL PRESSURE (MAP) SIGNIFICANTLY DECREASED BY 5, 3 AND 3 MMHG, RESPECTIVELY, FROM BASELINE AT 6 WEEKS (P < .05), BUT WERE NO LONGER SIGNIFICANT AT 12 WEEKS. IN THE IY GROUP, 24 H SBP WAS REDUCED BY 6 MMHG AT 12 WEEKS COMPARED TO BASELINE (P = .05). 24 H DBP (P < .01) AND MAP (P < .05) DECREASED SIGNIFICANTLY EACH BY 5 MMHG. NO DIFFERENCES WERE OBSERVED IN CATECHOLAMINE OR CORTISOL METABOLISM TO EXPLAIN THE DECREASE IN BP IN THE IY GROUP AT 12 WEEKS. TWELVE WEEKS OF IY PRODUCES CLINICALLY MEANINGFUL IMPROVEMENTS IN 24 H SBP AND DBP. LARGER STUDIES ARE NEEDED TO ESTABLISH THE LONG TERM EFFICACY, ACCEPTABILITY, UTILITY AND POTENTIAL MECHANISMS OF IY TO CONTROL BP. 2011 5 945 41 EFFECTS OF A 12-WEEK YOGA VERSUS A 12-WEEK EDUCATIONAL FILM INTERVENTION ON SYMPTOMS OF RESTLESS LEGS SYNDROME AND RELATED OUTCOMES: AN EXPLORATORY RANDOMIZED CONTROLLED TRIAL. STUDY OBJECTIVES: TO ASSESS THE EFFECTS OF A YOGA VERSUS EDUCATIONAL FILM (EF) PROGRAM ON RESTLESS LEGS SYNDROME (RLS) SYMPTOMS AND RELATED OUTCOMES IN ADULTS WITH RLS. METHODS: FORTY-ONE COMMUNITY-DWELLING, AMBULATORY NONPREGNANT ADULTS WITH MODERATE TO SEVERE RLS WERE RANDOMIZED TO A 12-WEEK YOGA (N = 19) OR EF PROGRAM (N = 22). IN ADDITION TO ATTENDING CLASSES, ALL PARTICIPANTS COMPLETED PRACTICE/TREATMENT LOGS. YOGA GROUP PARTICIPANTS WERE ASKED TO PRACTICE AT HOME 30 MINUTES PER DAY ON NONCLASS DAYS; EF PARTICIPANTS WERE INSTRUCTED TO RECORD ANY RLS TREATMENTS USED ON THEIR DAILY LOGS. CORE OUTCOMES ASSESSED PRETREATMENT AND POSTTREATMENT WERE RLS SYMPTOMS AND SYMPTOM SEVERITY (INTERNATIONAL RLS STUDY GROUP SCALE (IRLS) AND RLS ORDINAL SCALE), SLEEP QUALITY, MOOD, PERCEIVED STRESS, AND QUALITY OF LIFE (QOL). RESULTS: THIRTY ADULTS (13 YOGA, 17 EF), AGED 24 TO 73 (MEAN = 50.4 +/- 2.4 YEARS), COMPLETED THE 12-WEEK STUDY (78% FEMALE, 80.5% WHITE). POST-INTERVENTION, BOTH GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN RLS SYMPTOMS AND SEVERITY, PERCEIVED STRESS, MOOD, AND QOL-MENTAL HEALTH (P 3-POINT REDUCTION IN PSQI) AT 12 WEEKS VARIED BY CHANGES IN PAIN AND PHYSICAL FUNCTION AT 6 WEEKS. KEY RESULTS: AMONG PARTICIPANTS (MEAN AGE = 46.0, 64% FEMALE, 82% NON-WHITE), NEARLY ALL (92%) REPORTED POOR SLEEP QUALITY (PSQI > 5) AT BASELINE. AT 12 WEEKS, MODEST IMPROVEMENTS IN SLEEP QUALITY WERE OBSERVED AMONG THE YOGA (PSQI MEAN DIFFERENCE [MD] = - 1.19, 95% CONFIDENCE INTERVAL [CI] - 1.82, - 0.55) AND PT (PSQI MD = - 0.91, 95% CI - 1.61, - 0.20) GROUPS. PARTICIPANTS WHO REPORTED A >/= 30% IMPROVEMENT IN PAIN OR PHYSICAL FUNCTION AT 6 WEEKS, COMPARED WITH THOSE WHO IMPROVED < 10%, WERE MORE LIKELY TO BE A SLEEP QUALITY RESPONDER AT 12 WEEKS (ODDS RATIO [OR] = 3.51, 95% CI 1.73, 7.11 AND OR = 2.16, 95% CI 1.18, 3.95, RESPECTIVELY). RESULTS WERE SIMILAR AT 52 WEEKS. CONCLUSION: IN A SAMPLE OF ADULTS WITH CLBP, VIRTUALLY ALL WITH POOR SLEEP QUALITY PRIOR TO INTERVENTION, MODEST BUT STATISTICALLY SIGNIFICANT IMPROVEMENTS IN SLEEP QUALITY WERE OBSERVED WITH BOTH YOGA AND PT. IRRESPECTIVE OF TREATMENT, CLINICALLY IMPORTANT SLEEP IMPROVEMENTS AT THE END OF THE INTERVENTION WERE ASSOCIATED WITH MID-INTERVENTION PAIN AND PHYSICAL FUNCTION IMPROVEMENTS. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT01343927. 2020 18 1787 44 PREFERENCE AND EXPECTATION FOR TREATMENT ASSIGNMENT IN A RANDOMIZED CONTROLLED TRIAL OF ONCE- VS TWICE-WEEKLY YOGA FOR CHRONIC LOW BACK PAIN. BACKGROUND: IN STUDIES INVOLVING NONPHARMACOLOGICAL COMPLEMENTARY AND ALTERNATIVE MEDICINE INTERVENTIONS, PARTICIPANT BLINDING IS VERY DIFFICULT. PARTICIPANT EXPECTATIONS MAY AFFECT PERCEIVED BENEFIT OF THERAPY. IN STUDIES OF YOGA AS TREATMENT FOR CHRONIC LOW BACK PAIN, LITTLE IS KNOWN ABOUT THE RELATIONSHIP BETWEEN PATIENT EXPECTATIONS AND PREFERENCES ON OUTCOMES. THIS STUDY WAS DESIGNED TO IDENTIFY BASELINE PREDICTORS OF PREFERENCE AND TO DETERMINE IF EXPECTATIONS AND PREFERENCES FOR DIFFERENT DOSES OF YOGA AFFECT BACK-RELATED FUNCTION AND LOW BACK PAIN INTENSITY. METHODS: THIS WAS A SECONDARY DATA ANALYSIS OF A 12-WEEK RANDOMIZED CONTROLLED TRIAL COMPARING ONCE-WEEKLY VS TWICE-WEEKLY YOGA FOR TREATMENT OF CHRONIC LOW BACK PAIN IN 93 ADULTS FROM A PREDOMINANTLY LOW-INCOME MINORITY POPULATION. AT BASELINE, PARTICIPANTS WERE ASKED ABOUT BACK FUNCTION, BACK PAIN, TREATMENT EXPECTATIONS, AND TREATMENT PREFERENCES. WE CREATED A VARIABLE "CONCORDANCE" TO DESCRIBE THE MATCHING OF PARTICIPANT PREFERENCE TO RANDOMIZED TREATMENT. OUR OUTCOME VARIABLES WERE CHANGE IN BACK FUNCTION AND PAIN INTENSITY AFTER 12 WEEKS OF YOGA INSTRUCTION. WE PERFORMED LOGISTIC REGRESSION TO IDENTIFY PREDICTORS OF PREFERENCE FOR ONCE- OR TWICE-WEEKLY YOGA INSTRUCTION. WE CREATED LINEAR REGRESSION MODELS TO IDENTIFY INDEPENDENT ASSOCIATIONS BETWEEN EXPECTATIONS, PREFERENCE, CONCORDANCE, AND OUTCOMES. RESULTS: WORSE BACK FUNCTION AT BASELINE WAS ASSOCIATED WITH 20% HIGHER ODDS OF PREFERRING TWICE-WEEKLY YOGA (OR 1.2, CI 1.1, 1.3). INDIVIDUALS WITH HIGHER EXPECTATION SCORES FOR TWICE-WEEKLY YOGA HAD 90% HIGHER ODDS OF PREFERRING TWICE-WEEKLY VS ONCE-WEEKLY YOGA (OR 1.9, CI 1.3, 2.7). INDIVIDUALS WITH HIGHER EXPECTATION SCORES FOR ONCE-WEEKLY YOGA HAD 40% LESS ODDS OF PREFERRING TWICE-WEEKLY YOGA (OR 0.6, CI 0.5, 0.9). AFTER CONTROLLING FOR BASELINE CHARACTERISTICS, WE FOUND NO STATISTICALLY SIGNIFICANT RELATIONSHIP BETWEEN TREATMENT OUTCOMES, PREFERENCE, EXPECTATION SCORES, OR CONCORDANCE. CONCLUSION: IN A POPULATION OF PREDOMINANTLY LOW-INCOME MINORITY PARTICIPANTS WITH CHRONIC LOW BACK PAIN, WORSE BACK FUNCTION WAS ASSOCIATED WITH PREFERENCE FOR MORE FREQUENT YOGA CLASSES. THOSE WHO PREFERRED MORE YOGA CLASSES HAD HIGHER EXPECTATIONS FOR THOSE CLASSES. TWELVE-WEEK CHANGE IN BACK PAIN INTENSITY AND BACK FUNCTION WERE NOT AFFECTED BY DOSING PREFERENCE, EXPECTATION SCORE, OR CONCORDANCE. MORE RESEARCH IS NEEDED TO BETTER MEASURE AND QUANTIFY PREFERENCE, EXPECTATIONS, AND THEIR RELATIONSHIP TO OUTCOMES IN YOGA RESEARCH. 2015 19 1133 45 EFFICACY OF YOGA FOR VASOMOTOR SYMPTOMS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THIS STUDY AIMS TO DETERMINE THE EFFICACY OF YOGA IN ALLEVIATING VASOMOTOR SYMPTOMS (VMS) FREQUENCY AND BOTHER. METHODS: THIS STUDY WAS A THREE-BY-TWO FACTORIAL, RANDOMIZED CONTROLLED TRIAL. ELIGIBLE WOMEN WERE RANDOMIZED TO YOGA (N = 107), EXERCISE (N = 106), OR USUAL ACTIVITY (N = 142), AND WERE SIMULTANEOUSLY RANDOMIZED TO A DOUBLE-BLIND COMPARISON OF OMEGA-3 FATTY ACID (N = 177) OR PLACEBO (N = 178) CAPSULES. YOGA INTERVENTION CONSISTED OF 12 WEEKLY 90-MINUTE YOGA CLASSES WITH DAILY HOME PRACTICE. PRIMARY OUTCOMES WERE VMS FREQUENCY AND BOTHER ASSESSED BY DAILY DIARIES AT BASELINE, 6 WEEKS, AND 12 WEEKS. SECONDARY OUTCOMES INCLUDED INSOMNIA SYMPTOMS (INSOMNIA SEVERITY INDEX) AT BASELINE AND 12 WEEKS. RESULTS: AMONG 249 RANDOMIZED WOMEN, 237 (95%) COMPLETED 12-WEEK ASSESSMENTS. THE MEAN BASELINE VMS FREQUENCY WAS 7.4 PER DAY (95% CI, 6.6 TO 8.1) IN THE YOGA GROUP AND 8.0 PER DAY (95% CI, 7.3 TO 8.7) IN THE USUAL ACTIVITY GROUP. INTENT-TO-TREAT ANALYSES INCLUDED ALL PARTICIPANTS WITH RESPONSE DATA (N = 237). THERE WAS NO DIFFERENCE BETWEEN INTERVENTION GROUPS IN THE CHANGE IN VMS FREQUENCY FROM BASELINE TO 6 AND 12 WEEKS (MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 6 WK, -0.3 [95% CI, -1.1 TO 0.5]; MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 12 WK, -0.3 [95% CI, -1.2 TO 0.6]; P = 0.119 ACROSS BOTH TIME POINTS). RESULTS WERE SIMILAR FOR VMS BOTHER. AT WEEK 12, YOGA WAS ASSOCIATED WITH AN IMPROVEMENT IN INSOMNIA SYMPTOMS (MEAN DIFFERENCE [YOGA - USUAL ACTIVITY] IN THE CHANGE IN INSOMNIA SEVERITY INDEX, 1.3 [95% CI, -2.5 TO -0.1]; P = 0.007). CONCLUSIONS: AMONG HEALTHY WOMEN, 12 WEEKS OF YOGA CLASS PLUS HOME PRACTICE, COMPARED WITH USUAL ACTIVITY, DO NOT IMPROVE VMS FREQUENCY OR BOTHER BUT REDUCE INSOMNIA SYMPTOMS. 2014 20 111 32 A PILOT STUDY OF A HATHA YOGA TREATMENT FOR MENOPAUSAL SYMPTOMS. OBJECTIVE: TO ASSESS THE FEASIBILITY AND EFFICACY OF A YOGA TREATMENT FOR MENOPAUSAL SYMPTOMS. BOTH PHYSIOLOGIC AND SELF-REPORTED MEASURES OF HOT FLASHES WERE INCLUDED. METHODS: A PROSPECTIVE WITHIN-GROUP PILOT STUDY WAS CONDUCTED. PARTICIPANTS WERE 12 PERI- AND POST-MENOPAUSAL WOMEN EXPERIENCING AT LEAST 4 MENOPAUSAL HOT FLASHES PER DAY, AT LEAST 4 DAYS PER WEEK. ASSESSMENTS WERE ADMINISTERED BEFORE AND AFTER COMPLETION OF A 10-WEEK YOGA PROGRAM. PRE- AND POST-TREATMENT MEASURES INCLUDED: SEVERITY OF QUESTIONNAIRE-RATED MENOPAUSAL SYMPTOMS (WIKLUND SYMPTOM CHECK LIST), FREQUENCY, DURATION, AND SEVERITY OF HOT FLASHES (24-H AMBULATORY SKIN-CONDUCTANCE MONITORING; HOT-FLASH DIARY), INTERFERENCE OF HOT FLASHES WITH DAILY LIFE (HOT FLASH RELATED DAILY INTERFERENCE SCALE), AND SUBJECTIVE SLEEP QUALITY (PITTSBURGH SLEEP QUALITY INDEX). YOGA CLASSES INCLUDED BREATHING TECHNIQUES, POSTURES, AND RELAXATION POSES DESIGNED SPECIFICALLY FOR MENOPAUSAL SYMPTOMS. PARTICIPANTS WERE ASKED TO PRACTICE AT HOME 15 MIN EACH DAY IN ADDITION TO WEEKLY CLASSES. RESULTS: ELEVEN WOMEN COMPLETED THE STUDY AND ATTENDED A MEAN OF 7.45 (S.D. 1.63) CLASSES. SIGNIFICANT PRE- TO POST-TREATMENT IMPROVEMENTS WERE FOUND FOR SEVERITY OF QUESTIONNAIRE-RATED TOTAL MENOPAUSAL SYMPTOMS, HOT-FLASH DAILY INTERFERENCE; AND SLEEP EFFICIENCY, DISTURBANCES, AND QUALITY. NEITHER 24-H MONITORING NOR ACCOMPANYING DIARIES YIELDED SIGNIFICANT CHANGES IN HOT FLASHES. CONCLUSIONS: THE YOGA TREATMENT AND STUDY PROCEDURES WERE FEASIBLE FOR MIDLIFE WOMEN. IMPROVEMENT IN SYMPTOM PERCEPTIONS AND WELL BEING WARRANT FURTHER STUDY OF YOGA FOR MENOPAUSAL SYMPTOMS, WITH A LARGER NUMBER OF WOMEN AND INCLUDING A CONTROL GROUP. 2007